Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 1 of 1012345...10...Last »

The X Factor at SXSW

Three healthcare advertising agencies came together at South By Southwest to create a wide new range of possibilities for the ever-growing Health and MedTech Track.

Read More »

Longer night fasting tied to reduced breast cancer recurrence

For breast cancer survivors, the risk of recurrence may be tied to how many hours they fast at night, a new study suggests.

Read More »

Longer night fasting tied to reduced breast cancer recurrence

<span class="articleLocation”>(Reuters Health) – For breast cancer survivors, the risk of recurrence may be tied to how many hours they fast at night, a new study suggests. Women in the study were more likely to have their breast cancer come back if they fasted overnight for less than 13 hours, researchers found. While prolonged fasting […]

Read More »

U.S. FTC sues Endo alleging antitrust violations

The U.S. Federal Trade Commission said it filed a complaint in a district court accusing Endo International Plc of violating antitrust laws by striking “pay-for-delay” deals.

Read More »

Takeda Launches Multi-Year Research Partnership for IBD

Takeda Pharmaceuticals U.S.A. announced a multi-year research partnership with two world-leading academic centers with a proven long-term commitment to IBD research and care.

Read More »

GlaxoSmithKline promises reduced drug patents to help world’s poor

GlaxoSmithKline is to adopt a graduated approach to patenting its medicines, depending on the wealth of different countries, in order to make drugs more affordable in the developing world.   Britain’s biggest drugmaker said on Thursday it would not file patents in low-income states, leaving the way clear for generic companies to make cheap copies […]

Read More »

Baricitinib Results in Significant Improvements for Certain RA Patients

Phase 3 Study Findings Demonstrate Treatment with Baricitinib Results in Significant Improvements for Patients with Rheumatoid Arthritis Who Had Inadequate Response to Biologics Pivotal RA-BEACON Study Published in New England Journal of Medicine 07:00 ET from Eli Lilly and Company; Incyte Corporation   INDIANAPOLIS, March 31, 2016 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) […]

Read More »

1,000+ Women Suing Johnson & Johnson for Alleged Cover Up

1,000+ Women are Suing Johnson & Johnson for Allegedly Covering Up Baby Powder Cancer Risk for Decades     March 31, 2016By Alex Keown, BioSpace.com Breaking News Staff   WASHINGTON – More than 1,000 women have joined a lawsuit against Johnson & Johnson (JNJ) claiming the company failed to provide information about risks of ovarian […]

Read More »

Jazz Pharmaceuticals Announces FDA Approval of Defitelio for Hepatic VOD

Jazz Pharmaceuticals Announces FDA Approval of Defitelio (defibrotide sodium) for the Treatment of Hepatic Veno-Occlusive Disease (VOD) with Renal or Pulmonary Dysfunction Following Hematopoietic Stem-Cell Transplantation (HSCT)   First and Only FDA-Approved Therapy for Patients with this Rare, Potentially Fatal Complication     DUBLIN, March 30, 2016 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that […]

Read More »

FDA permits use of Roche test to screen donated blood for Zika

The U.S. Food and Drug Administration said it would allow the use of an experimental test to screen donated blood for the Zika virus.

Read More »

Sun Pharma Gains 14 Japanese Brands From Novartis in $293 Million Deal

Sun Pharma secured a firm toehold in the Japanese market after striking a $293 million deal with Novartis AG to acquire 14 of Novartis’ branded drug portfolio program in that country.

Read More »

OPKO Receives Complete Response Letter from FDA for RAYALDEE NDA

Sole issue relates to third-party manufacturing observations: no new clinical studies were requested and no safety or efficacy issues were identified.

Read More »

InterbrandHealth Report Reveals Top Biopharma Brands: Leaders Are Addressing Needs of Healthcare Professionals to Tackle the Challenges of Today

Pfizer and the Roche Group claim the #1 and #2 positions for leading the way in redefining their value to HCPs   March 30, 2016 01:26 AM Eastern Daylight Time   NEW YORK–(BUSINESS WIRE)–A global study released today by InterbrandHealth identifies the biopharma companies that are addressing healthcare professionals’ (HCPs), payers’, and policymakers’ needs. A […]

Read More »

FreshBlood Embraces Integrated Marketing Expert Tom Panchak

Panchak Named Senior Digital Strategist at FreshBlood’s Consortium of Healthcare Industry Experts.

Read More »

FDA panel backs Acadia drug for psychosis linked to Parkinson’s

An advisory panel to the U.S. Food and Drug Administration backed an approval for Acadia Pharmaceuticals Inc’s drug for psychosis related to Parkinson’s disease. Nuplazid’s benefits outweighed the risks, the panel said, after 12 members voted in favor of the treatment and two against. Acadia’s shares, which were halted for trading during market hours on […]

Read More »

Bloomberg, others give $125 million for immunotherapy cancer research

Billionaire Michael Bloomberg and other philanthropists are donating $125 million to Johns Hopkins University for a new institute devoted to immunotherapy cancer research, the Baltimore school said on Tuesday. Bloomberg, founder of the business and market news firm bearing his name and a former New York City mayor, and Sidney Kimmel, founder of Jones Apparel […]

Read More »

Obama calls for more funds, new attitude to fight opioid epidemic

With a nod to his own drug use as a young man, President Barack Obama on Tuesday called for more funding and a new approach to help people addicted to heroin and prescription drugs, seeking to shine a public spotlight on an increasingly deadly killer. During an appearance at a drug abuse summit in Atlanta, […]

Read More »

Looking ahead after SXSW

Although SXSW 2016 lacked a major platform launch, it did further the tech discussion in key areas.

Read More »

Ariad Cuts Another 25% of Workforce at HQ

March 29, 2016 By Alex Keown, BioSpace.com Breaking News Staff   CAMBRIDGE, Mass. – Citing a need to invest in growth of its drug products, Ariad Pharmaceuticals (ARIA) slashed 25 percent of employees in the U.S. and Europe, the company announced Tuesday afternoon. Ariad said the job reductions are part of a strategic review aimed […]

Read More »

DURECT Announces Resubmission of REMOXY NDA to the U.S. FDA

DURECT announced its licensee, Pain Therapeutics, has resubmitted the New Drug Application for REMOXY (oxycodone capsules CII) to the U.S. Food and Drug Administration.

Read More »

Page 1 of 1012345...10...Last »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2017 Focus: Manufacturer of the Year, Top 50 Pharma, HBA and more!

Subscribe

Ad Right Bottom

Main Navigation